Literature DB >> 25937122

Selective permeabilization of cervical cancer cells to an ionic DNA-binding cytotoxin by activation of P2Y receptors.

Maurish Bukhari1, Han Deng1, Noelle Jones1, Zachary Towne1, Craig D Woodworth1, Damien S K Samways2.   

Abstract

Extracellular ATP is known to permeabilize certain cell types to polyatomic cations like YO-PRO1. Here, we report that extracellularly applied ATP stimulated rapid uptake and accumulation of an otherwise weakly membrane permeable fluorescent DNA-binding cytotoxin, Hoechst 33258, into cervical cancer cells. While ATP stimulated Hoechst 33258 uptake in 20-70% of cells from seven cervical cancer cell lines, it stimulated uptake in less than 8% of cervical epithelial cells obtained from the normal transformation zone and ectocervix tissue of 11 patients. ATP-evoked Hoechst 33258 uptake was independent of ionotropic P2X receptors, but dependent on activation of P2Y receptors. Thus, we show here that cervical cancer cells can be selectively induced to take up and accumulate an ionic cytotoxin by exposure to extracellular ATP.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Ca(2+); Cervical cancer; Doxorubicin; Drug delivery; Hoechst 33258; P2X; P2Y; Permeability; Pibenzimol; Purinergic

Mesh:

Substances:

Year:  2015        PMID: 25937122      PMCID: PMC4497545          DOI: 10.1016/j.febslet.2015.04.044

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

Review 1.  Topoisomerase I poisons and suppressors as anticancer drugs.

Authors:  C Bailly
Journal:  Curr Med Chem       Date:  2000-01       Impact factor: 4.530

2.  DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors.

Authors:  A Y Chen; C Yu; B Gatto; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

3.  Regulation by retinoids of P2Y2 nucleotide receptor mRNA in human uterine cervical cells.

Authors:  G I Gorodeski; P Burfeind; S U Gan; D Pal; F W Abdul-Karim
Journal:  Am J Physiol       Date:  1998-09

Review 4.  Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.

Authors:  Dietrich Keppler
Journal:  Handb Exp Pharmacol       Date:  2011

Review 5.  The roles of copper transporters in cisplatin resistance.

Authors:  Macus Tien Kuo; Helen H W Chen; Im-Sook Song; Niramol Savaraj; Toshihisa Ishikawa
Journal:  Cancer Metastasis Rev       Date:  2007-03       Impact factor: 9.264

6.  Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells.

Authors:  Xin Li; Xiaoping Qi; Lingyin Zhou; Deborah Catera; Neal S Rote; Judith Potashkin; Fadi W Abdul-Karim; George I Gorodeski
Journal:  Gynecol Oncol       Date:  2007-05-04       Impact factor: 5.482

7.  Pharmacological properties of a pore induced by raising intracellular Ca2+.

Authors:  R X Faria; R A M Reis; C M Casabulho; A V P Alberto; F P de Farias; A Henriques-Pons; L A Alves
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-25       Impact factor: 4.249

8.  Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells.

Authors:  Damir Janigro; Catalin Perju; Vincent Fazio; Kerri Hallene; Gabriele Dini; Mukesh K Agarwal; Luca Cucullo
Journal:  BMC Cancer       Date:  2006-03-17       Impact factor: 4.430

9.  Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons.

Authors:  David P Roberson; Sagi Gudes; Jared M Sprague; Haley A W Patoski; Victoria K Robson; Felix Blasl; Bo Duan; Seog Bae Oh; Bruce P Bean; Qiufu Ma; Alexander M Binshtok; Clifford J Woolf
Journal:  Nat Neurosci       Date:  2013-05-19       Impact factor: 24.884

10.  Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistance.

Authors:  Albert J van Hell; Manuel N Melo; Wim J van Blitterswijk; Dayana M Gueth; Tanya M Braumuller; Lilia R C Pedrosa; Ji-Ying Song; Siewert J Marrink; Gerben A Koning; Jos Jonkers; Marcel Verheij
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  4 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 2.  The P2 purinoceptors in prostate cancer.

Authors:  Zilin Wang; Sha Zhu; Sirui Tan; Yuhao Zeng; Hao Zeng
Journal:  Purinergic Signal       Date:  2022-06-30       Impact factor: 3.765

Review 3.  Purinergic signaling and tumor microenvironment in cervical Cancer.

Authors:  Marta Schmidt Pfaffenzeller; Maria Luiza Mukai Franciosi; Andréia Machado Cardoso
Journal:  Purinergic Signal       Date:  2020-03-13       Impact factor: 3.765

4.  KCa3.1-dependent uptake of the cytotoxic DNA-binding dye Hoechst 33258 into cancerous but not healthy cervical cells.

Authors:  Maurish Bukhari; Han Deng; Darren Sipes; Marisa Ruane-Foster; Kayla Purdy; Craig D Woodworth; Shantanu Sur; Damien S K Samways
Journal:  J Biol Chem       Date:  2020-11-23       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.